CTKB Cytek Biosciences, Inc.
P/E
--
Forward P/E
370.37
Price/Sales
3.414
Beta
1.16
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Cytek Biosciences third quarter 2026 revenue of $53M beat estimates as gross margins expanded to 59%
Cytek Biosciences reported third quarter 2026 revenue of $53.2 million, a 2% year-over-year increase that slightly exceeded analyst expectations. The company...
Cytek Biosciences Inc Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
Cytek Biosciences is projected to report Q3 2026 revenue of $53.05 million and a loss per share of $0.07, with its current stock price of $6.13 trading...